Westend Capital Management’s Organon & Co OGN Stock Holding History

Westend Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.24K	Hold	313	–	–	﹤0.01%	185
2026 Q1	$1.88K	Hold	313	–	–	﹤0.01%	215
2025 Q4	$2.24K	Hold	313	–	–	﹤0.01%	208
2025 Q3	$3.34K	Hold	313	–	–	﹤0.01%	216
2025 Q2	$3.03K	Sell	313 -180	-37%	-$1.86K	﹤0.01%	194
2025 Q1	$7.34K	Buy	493 +30	+6%	+$461	﹤0.01%	131
2024 Q4	$6.91K	Hold	463	–	–	﹤0.01%	142
2024 Q3	$8.86K	Hold	463	–	–	﹤0.01%	136
2024 Q2	$9.4K	Hold	463	–	–	﹤0.01%	106
2024 Q1	$8.7K	Buy	+463	New	+$7.95K	﹤0.01%	129

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Westend Capital Management's OGN Position: Q2 2026 in Review

Westend Capital Management held its Organon & Co (OGN) position steady in Q2 2026 at 313 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Westend Capital Management first reported a position in OGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.4K in Q2 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Westend Capital Management held 313 shares of Organon & Co worth $4.24K as of Q2 2026.
Westend Capital Management left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Westend Capital Management's portfolio in Q2 2026, its #185 holding.
Westend Capital Management first reported a position in Organon & Co in Q1 2024 and has held it in 10 quarters since.
Westend Capital Management's Organon & Co position peaked at $9.4K in Q2 2024.
633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Westend Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.